DK4039800T3 - Konstrueret flerkomponentsystem til identifikation og karakterisering af t-cellreceptorer og t-cellantigener - Google Patents

Konstrueret flerkomponentsystem til identifikation og karakterisering af t-cellreceptorer og t-cellantigener Download PDF

Info

Publication number
DK4039800T3
DK4039800T3 DK22150892.2T DK22150892T DK4039800T3 DK 4039800 T3 DK4039800 T3 DK 4039800T3 DK 22150892 T DK22150892 T DK 22150892T DK 4039800 T3 DK4039800 T3 DK 4039800T3
Authority
DK
Denmark
Prior art keywords
cell
characterization
identification
multicomponent system
antigens
Prior art date
Application number
DK22150892.2T
Other languages
English (en)
Other versions
DK4039800T5 (da
Inventor
Reagan Micheal Jarvis
Ryan Edward Hill
Luke Benjamin Pase
Original Assignee
Genovie Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genovie Ab filed Critical Genovie Ab
Publication of DK4039800T3 publication Critical patent/DK4039800T3/da
Application granted granted Critical
Publication of DK4039800T5 publication Critical patent/DK4039800T5/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C12N2310/153—Nucleic acids forming more than 2 strands, e.g. TFOs with the aid of a protein, e.g. recombinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/18—Type of nucleic acid acting by a non-sequence specific mechanism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00—Vectors comprising a targeting moiety
    • C12N2810/10—Vectors comprising a non-peptidic targeting moiety

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
DK22150892.2T 2016-11-07 2017-11-07 Konstrueret flerkomponentsystem til identifikation og karakterisering af t-cellreceptorer og t-cellantigener DK4039800T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201670872 2016-11-07
EP17800759.7A EP3535387B1 (en) 2016-11-07 2017-11-07 An engineered multi-component system for identification and characterisation of t-cell receptors and t-cell antigens

Publications (2)

Publication Number Publication Date
DK4039800T3 true DK4039800T3 (da) 2024-01-02
DK4039800T5 DK4039800T5 (da) 2024-07-29

Family

ID=57460292

Family Applications (2)

Application Number Title Priority Date Filing Date
DK22150892.2T DK4039800T5 (da) 2016-11-07 2017-11-07 Konstrueret flerkomponentsystem til identifikation og karakterisering af t-cellreceptorer og t-cellantigener
DK17800759.7T DK3535387T3 (da) 2016-11-07 2017-11-07 Konstrueret flerkomponentsystem til identifikation og karakterisering af t-cellereceptorer og t-celleantigener

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK17800759.7T DK3535387T3 (da) 2016-11-07 2017-11-07 Konstrueret flerkomponentsystem til identifikation og karakterisering af t-cellereceptorer og t-celleantigener

Country Status (12)

Country Link
US (3) US12012610B2 (da)
EP (4) EP4332232A3 (da)
JP (3) JP7645606B2 (da)
KR (3) KR102833088B1 (da)
CN (3) CN118909953A (da)
AU (2) AU2017352589B2 (da)
CA (1) CA3038917A1 (da)
DK (2) DK4039800T5 (da)
ES (3) ES2906827T3 (da)
FI (1) FI4039800T3 (da)
NZ (2) NZ794207A (da)
WO (1) WO2018083316A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4332232A3 (en) 2016-11-07 2024-05-08 Genovie AB An engineered multi-component system for identification and characterisation of t-cell receptors and t-cell antigens
EP3535393B1 (en) 2016-11-07 2021-09-22 Genovie AB A two-part device for t-cell receptor synthesis and stable genomic integration to tcr-presenting cells
CN112513279B (zh) * 2018-07-09 2025-01-17 杰诺维有限公司 用于在重组酶介导的核酸序列向工程化的接受细胞发生盒交换整合期间追踪和操纵细胞的细胞表面标签交换(cste)系统
WO2021219619A1 (en) 2020-04-27 2021-11-04 Genovie Ab Methods to generate vaccine compositions that prime human leukocyte antigen class i restricted cd8 t-cell responses against viral non-virion-integral derived epitopes
EP4570263A1 (en) 2023-12-15 2025-06-18 Genovie AB Tcrs recognizing g12v mutated ras and uses thereof
WO2025125590A2 (en) 2023-12-15 2025-06-19 Genovie Ab Tcr recognizing g12v mutated ras and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003065977A2 (en) 2001-11-20 2003-08-14 Dana-Farber Cancer Institute Modified antigen-presenting cells
US20100291633A1 (en) 2007-09-03 2010-11-18 Thorsten Selmer Method of cloning at least one nucleic acid molecule of interest using type iis restriction endonucleases, and corresponding cloning vectors, kits and system using type iis restriction endonucleases
EP2395087A1 (en) 2010-06-11 2011-12-14 Icon Genetics GmbH System and method of modular cloning
EP2601521B1 (en) 2010-08-06 2018-05-02 Ludwig-Maximilians-Universität München Identification of t cell target antigens
WO2013144257A1 (en) 2012-03-27 2013-10-03 Dsm Ip Assets B.V. Cloning method
JP6126804B2 (ja) 2012-07-25 2017-05-10 国立大学法人富山大学 T細胞受容体のクローニング方法
AU2014235968B2 (en) 2013-03-21 2018-05-24 Ospedale San Raffaele Srl Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
ES2740930T3 (es) 2014-03-14 2020-02-07 Immunocore Ltd Bibliotecas de TCR
KR20160145186A (ko) 2014-04-24 2016-12-19 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 입양 세포 요법 생성물을 생성하기 위한 유도 만능 줄기 세포의 응용
GB201407852D0 (en) * 2014-05-02 2014-06-18 Iontas Ltd Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules
KR102546296B1 (ko) 2014-10-31 2023-06-21 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 변형된 t 세포에서 유전자 발현의 변경 및 그의 용도
CA2964785A1 (en) * 2014-11-05 2016-05-12 Board Of Regents, The University Of Texas System Gene modified immune effector cells and engineered cells for expansion of immune effector cells
DK3271382T3 (da) 2015-03-16 2020-05-04 Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft Fremgangsmåde til detektion af nye immunogene T-celleepitoper og isolering af nye antigenspecifikke T-cellereceptorer ved hjælp af et MHC-cellebibliotek
AU2016273213B2 (en) 2015-06-01 2019-03-14 Medigene Immunotherapies Gmbh T cell receptor library
CN105316362B (zh) * 2015-08-19 2020-03-17 暨南大学 一种Dual-RMCE介导的TCR基因置换系统及其方法
EP4332232A3 (en) 2016-11-07 2024-05-08 Genovie AB An engineered multi-component system for identification and characterisation of t-cell receptors and t-cell antigens
KR102606929B1 (ko) 2016-11-07 2023-11-27 제노비에 에이비 동족 항원과 t-세포 수용체 상호작용의 발견 및 특징규명을 위한 조작된 2-부분 세포 디바이스
US20200095574A1 (en) 2016-11-07 2020-03-26 Genovie Ab An engineered multi-component system for identification and characterisation of t-cell receptors, t-cell antigens and their functional interaction
EP3535393B1 (en) 2016-11-07 2021-09-22 Genovie AB A two-part device for t-cell receptor synthesis and stable genomic integration to tcr-presenting cells
JP7335224B2 (ja) 2017-07-18 2023-08-29 ジェノヴィー エービー 全長t細胞受容体オープンリーディングフレームの迅速な組立ておよび多様化のための二成分ベクターライブラリシステム

Also Published As

Publication number Publication date
ES3034256T3 (en) 2025-08-14
EP3535387A1 (en) 2019-09-11
WO2018083316A1 (en) 2018-05-11
KR20240010103A (ko) 2024-01-23
KR102833088B1 (ko) 2025-07-10
JP2019534047A (ja) 2019-11-28
AU2017352589A1 (en) 2019-05-16
KR20190076991A (ko) 2019-07-02
KR102956777B1 (ko) 2026-04-23
EP4019625A1 (en) 2022-06-29
ES2968633T3 (es) 2024-05-13
JP2025122051A (ja) 2025-08-20
KR102625785B1 (ko) 2024-01-16
CN118909953A (zh) 2024-11-08
US20190359934A1 (en) 2019-11-28
JP7684271B2 (ja) 2025-05-27
NZ794207A (en) 2026-03-27
JP7645606B2 (ja) 2025-03-14
EP4039800A1 (en) 2022-08-10
DK3535387T3 (da) 2022-02-14
ES2906827T3 (es) 2022-04-20
EP4019625B1 (en) 2025-04-02
CN109923207B (zh) 2024-08-16
US20200339946A1 (en) 2020-10-29
US20250297211A1 (en) 2025-09-25
DK4039800T5 (da) 2024-07-29
EP4332232A2 (en) 2024-03-06
CA3038917A1 (en) 2018-05-11
JP2023025182A (ja) 2023-02-21
KR20240010545A (ko) 2024-01-23
EP3535387B1 (en) 2022-01-12
US12012610B2 (en) 2024-06-18
NZ752629A (en) 2023-04-28
AU2017352589B2 (en) 2024-08-08
FI4039800T3 (fi) 2023-12-15
AU2024205017A1 (en) 2024-08-15
EP4039800B1 (en) 2023-10-25
CN109923207A (zh) 2019-06-21
EP4332232A3 (en) 2024-05-08
CN118931845A (zh) 2024-11-12
EP4019625C0 (en) 2025-04-02
US12270047B2 (en) 2025-04-08

Similar Documents

Publication Publication Date Title
DK3551660T3 (da) Anti-ctla-4-antistoffer og fremgangsmåder til anvendelse deraf
DK3551221T3 (da) Hidtil ukendte t-cellereceptorer og immunterapi med anvendelse deraf
PL3558339T3 (pl) Multimeryczne polipeptydy modulujące limfocyty t i sposoby ich stosowania
DK3303394T3 (da) Anti-ctla-4-antistoffer og fremgangsmåder til anvendelse deraf
DK3563156T3 (da) Fremgangsmåde til separering af biomolekyler
DK3445787T3 (da) Sammensætninger og fremgangsmåder til omprogrammering af t-cellereceptorer under anvendelse af fusionsproteiner
DK3430378T3 (da) Indretninger og fremgangsmåder til modifikation af optiske egenskaber
DK3419625T3 (da) Fremgangsmåder til anvendelse af fxr-agonister
DK3398022T3 (da) Systemer og fremgangsmåder til tilpasning af uav-bane
DK3264799T3 (da) Fremgangsmåde og høreanordning til forbedret adskillelse af mållyde
DK3507047T3 (da) System og fremgangsmåde til adskillelse af en rørformig komponent
DK3419624T3 (da) Fremgangsmåder til anvendelse af fxr-agonister
DK3280441T3 (da) Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf
DK3259386T3 (da) Systemer og fremgangsmåder til udførelse af immunoassays
DK3207373T3 (da) Fremgangsmåde til analyse af indholdet af dråber og tilhørende indretning
DK3285544T3 (da) Fremgangsmåde og indretning til behandling af indretning-til-indretning-synkroniseringssekvens
DK3152569T3 (da) Midler og fremgangsmåder til bestemmelse af t-cellegenkendelse
DK3504051T3 (da) Anordning og fremgangsmåde til imprægnering af fiberstrukturer
DK4039800T5 (da) Konstrueret flerkomponentsystem til identifikation og karakterisering af t-cellreceptorer og t-cellantigener
DK3160964T3 (da) Arylreceptormodulatorer og fremgangsmåder til fremstilling og brug af samme
DK3426111T3 (da) Anordning og fremgangsmåde til opskumning af mælk
DK3405037T3 (da) Fremgangsmåde og system til inddeling af størrelsestilpassede fødevareartikler
DK3200596T3 (da) Stabiliseret olie og fremgangsmåder til fremstilling af denne
DK3132049T3 (da) Enhed og fremgangsmåder til anvendelse af enhed til detektering af aminoacidopatier
DK3280710T3 (da) Fremgangsmåde til fremstilling af androgenreceptorantagonister og mellemprodukter deraf